Letter of response to comment on: Efficacy and safety of BNT162b2 vaccination in solid cancer patients receiving anti-cancer therapy - A single centre prospective study

Detalles Bibliográficos
Autores principales: Shacham-Shmueli, Einat, Itay, Amit, Margalit, Ofer, Berger, Raanan, Halperin, Sharon, Jurkowicz, Menucha, Levin, Einav G., Levy, Itzchak, Olmer, Liraz, Regev-Yochay, Gili, Lustig, Yaniv, Rahav, Galia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616568/
https://www.ncbi.nlm.nih.gov/pubmed/34840027
http://dx.doi.org/10.1016/j.ejca.2021.10.019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616568/
https://www.ncbi.nlm.nih.gov/pubmed/34840027
http://dx.doi.org/10.1016/j.ejca.2021.10.019

Ejemplares similares